Table 1.

Selection of mutated peptides predicted to bind HLA-A2 with high affinity from whole exome sequences of tumor cell lines.

Mutation type	Prediction category	Patient
		KADA	ANRU
SNV	Non-synon. mutations	2554	323
	Predicted HLA-A2 peptides	1713	182
	Ordered HLA-A2 peptides	165	37
DNV,TNV	Non-synon. mutations	120	9
	Predicted HLA-A2 peptides	37	7
	Ordered HLA-A2 peptides	12	0
InDels	Non-synon. mutations	571	611
	Predicted HLA-A2 peptides	211	177
	Ordered HLA-A2 peptides	4	12
Total	Non-synon. mutations	3244	943
	Predicted HLA-A2 peptides	1961	366
	Ordered HLA-A2 peptides	181	49

SNV, single-nucleotide variant; DNV, double-nucleotide variant; TNV, triple-nucleotide variant; InDels, insertion/deletions.